Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-28

Clinical Trial Update: Bivalirudin in Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bivalirudin for acute myocardial infarction is described in a clinical trial update. The current status of the trial is listed as unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Acute Myocardial Infarction | Phase 3 | Status: UNKNOWN